General Information of Drug (ID: DMB0LLM)

Drug Name
BLI-1100
Indication
Disease Entry ICD 11 Status REF
Acne vulgaris ED80 Phase 2 [1]
Cross-matching ID
TTD ID
D02GGG

References

1 ClinicalTrials.gov (NCT01815450) BLI1100-202: BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris. U.S. National Institutes of Health.